TFS Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-14,750
| Closed | -$454K | – | 659 |
|
|
2017
Q1 | $454K | Buy |
+14,750
| New | +$454K | 0.15% | 256 |
|
|
2016
Q2 | – | Sell |
-17,487
| Closed | -$514K | – | 1014 |
|
|
2016
Q1 | $514K | Buy |
+17,487
| New | +$514K | 0.07% | 431 |
|
|
2015
Q3 | – | Sell |
-121,085
| Closed | -$5.45M | – | 936 |
|
|
2015
Q2 | $5.45M | Buy |
121,085
+99,470
| +460% | +$4.48M | 0.53% | 19 |
|
|
2015
Q1 | $662K | Sell |
21,615
-3
| -0% | -$92 | 0.06% | 461 |
|
|
2014
Q4 | $1.1M | Sell |
21,618
-72,153
| -77% | -$3.67M | 0.1% | 303 |
|
|
2014
Q3 | $3.71M | Buy |
+93,771
| New | +$3.71M | 0.32% | 62 |
|
|
2013
Q4 | – | Sell |
-20,168
| Closed | -$462K | – | 1514 |
|
|
2013
Q3 | $462K | Sell |
20,168
-1,981
| -9% | -$45.4K | 0.02% | 917 |
|
|
2013
Q2 | $392K | Buy |
+22,149
| New | +$392K | 0.02% | 1014 |
|